Clinical Trials in Yunnan, China
4 recruiting
Showing 1–6 of 6 trials
Recruiting
Phase 1Phase 2
Study of XNW28012 in Subjects With Advanced Solid Tumors Who Failed Standard Treatments
Ovarian CancerPancreatic CarcinomaAdvanced Solid Tumors+1 more
Evopoint Biosciences Inc.350 enrolled24 locationsNCT06799637
Recruiting
Not Applicable
Indometacin With or Without Aggressive Intravenous Hydration to Prevent Pancreatitis After Pancreatic Extracorporeal Shock Wave Lithotripsy
Pancreatitis, ChronicPancreatitis, AcutePancreatic Duct Stones
Changhai Hospital1,250 enrolled10 locationsNCT07202559
Recruiting
Phase 2
A Phase Ⅱ Study of RC108 in Combination With Furmonertinib for the First-line Treatment of EGFR-Mutated Combined MET-Positive Unresectable Locally Advanced or Recurrent Metastatic NSCLC
Non-small Cell Lung Cancer
RemeGen Co., Ltd.80 enrolled34 locationsNCT06962865
Recruiting
Phase 1Phase 2
A Study of RC148 As a Single Agent and Combination Therapy in Patients with Locally Advanced Unresectable or Metastatic Malignant Solid Tumors
Solid Tumor
RemeGen Co., Ltd.221 enrolled31 locationsNCT06016062
Recruiting
Phase 1
A Study to Assess Safety, Tolerability, and Pharmacokinetics of ABSK061 in Patients With Advanced Solid Tumors
Solid Tumor
Abbisko Therapeutics Co, Ltd85 enrolled22 locationsNCT05244551
Recruiting
Chinese Psoriasis Real World Evidence Research
Psoriasis
Second Affiliated Hospital, School of Medicine, Zhejiang University10,000 enrolled29 locationsNCT04465838